Oxford Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
Other funds holding WX
Oxford Asset Management's WX Position: Q4 2015 in Review
Oxford Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 400,000 shares — an estimated $17.3M sold.
Oxford Asset Management first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $17.3M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.
- Oxford Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
- Oxford Asset Management sold 400,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $17.3M.
- Oxford Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
- Oxford Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $17.3M in Q3 2015.
- 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.
Based on Oxford Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.